Boston Scientific Receives FDA Approval for TheraSphere™ Y-90 Glass MicrospheresPRNewsWire • 03/18/21
Boston Scientific (BSX) Down 2.1% Since Last Earnings Report: Can It Rebound?Zacks Investment Research • 03/05/21
Baring Private Equity Asia Announces Agreement to Sell Lumenis' Surgical Business to Boston Scientific for USD1.07 billionPRNewsWire • 03/03/21
Boston Scientific to spend $1.1 billion in cash to buy Lumentis LTD's surgical businessMarket Watch • 03/03/21
Boston Scientific Announces Agreement To Acquire Lumenis LTD. Surgical Business From Baring Private Equity AsiaPRNewsWire • 03/03/21
Boston Scientific Corporation (BSX) CEO Michael Mahoney on Q4 2020 Results - Earnings Call TranscriptSeeking Alpha • 02/03/21
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Boston Scientific Corporation of a Class Action Lawsuit and a Lead Plaintiff Deadline of February 2, 2021 - BSXNewsfile Corp • 02/02/21
DEADLINE TODAY: The Schall Law Firm Announces it is Investigating Claims Against Boston Scientific Corporation and Encourages Investors with Losses of $100,000 to Contact the FirmBusiness Wire • 02/02/21
BSX Final Deadline Today: Rosen, National Trial Counsel, Reminds Boston Scientific Corporation Investors of Important February 2 Deadline in Securities Class Action - BSXNewsfile Corp • 02/02/21
BSX ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of February 2, 2021 in the Class Action Filed on Behalf of Boston Scientific Corporation Limited ShareholdersNewsfile Corp • 02/01/21
DEADLINE TOMORROW: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Boston Scientific Corporation and Encourages Investors with Losses in Excess of $100,000 to Contact the FirmPRNewsWire • 02/01/21
BSX Final Deadline: Bronstein, Gewirtz & Grossman, LLC Reminds Boston Scientific Corporation Shareholders of Class Action and Lead Plaintiff Deadline: February 3, 2021GlobeNewsWire • 02/01/21